JP2004517098A5 - - Google Patents

Download PDF

Info

Publication number
JP2004517098A5
JP2004517098A5 JP2002551528A JP2002551528A JP2004517098A5 JP 2004517098 A5 JP2004517098 A5 JP 2004517098A5 JP 2002551528 A JP2002551528 A JP 2002551528A JP 2002551528 A JP2002551528 A JP 2002551528A JP 2004517098 A5 JP2004517098 A5 JP 2004517098A5
Authority
JP
Japan
Prior art keywords
alkyl
formula
solvate
salt
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002551528A
Other languages
English (en)
Japanese (ja)
Other versions
JP4460830B2 (ja
JP2004517098A (ja
Filing date
Publication date
Priority claimed from GBGB0031315.5A external-priority patent/GB0031315D0/en
Application filed filed Critical
Publication of JP2004517098A publication Critical patent/JP2004517098A/ja
Publication of JP2004517098A5 publication Critical patent/JP2004517098A5/ja
Application granted granted Critical
Publication of JP4460830B2 publication Critical patent/JP4460830B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002551528A 2000-12-21 2001-12-20 インドール誘導体 Expired - Fee Related JP4460830B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0031315.5A GB0031315D0 (en) 2000-12-21 2000-12-21 Indole derivatives
PCT/GB2001/005701 WO2002050031A1 (en) 2000-12-21 2001-12-20 Indole derivatives

Publications (3)

Publication Number Publication Date
JP2004517098A JP2004517098A (ja) 2004-06-10
JP2004517098A5 true JP2004517098A5 (https=) 2005-12-22
JP4460830B2 JP4460830B2 (ja) 2010-05-12

Family

ID=9905643

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002551528A Expired - Fee Related JP4460830B2 (ja) 2000-12-21 2001-12-20 インドール誘導体

Country Status (9)

Country Link
US (1) US7288564B2 (https=)
EP (1) EP1343757B1 (https=)
JP (1) JP4460830B2 (https=)
AT (1) ATE353875T1 (https=)
AU (1) AU2002217286A1 (https=)
DE (1) DE60126652T2 (https=)
ES (1) ES2282195T3 (https=)
GB (1) GB0031315D0 (https=)
WO (1) WO2002050031A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN2001000224A (es) 2000-10-19 2002-06-13 Pfizer Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti - inflamatorios y analgesicos.
SE0301446D0 (sv) 2003-05-16 2003-05-16 Astrazeneca Ab New Compounds
SE0402284D0 (sv) * 2004-09-21 2004-09-21 Astrazeneca Ab New heterocyclic amides
JP2008518957A (ja) * 2004-11-04 2008-06-05 メルク エンド カムパニー インコーポレーテッド ナイアシン受容体作動薬、そのような化合物を含んでいる組成物及び治療方法
WO2007044724A2 (en) * 2005-10-06 2007-04-19 Exelixis, Inc. Aminopyrimidine, aminopyridine and aniline derivatives inhibitors of pim-i and/or pim-3
TW200736227A (en) * 2005-12-23 2007-10-01 Astrazeneca Ab New compounds III
UY30121A1 (es) 2006-02-03 2007-08-31 Glaxo Group Ltd Nuevos compuestos
ES2392192T3 (es) * 2006-04-24 2012-12-05 Merck Canada Inc. Derivados de indol amida como antagonistas del receptor EP4
TWI433839B (zh) 2006-08-11 2014-04-11 Neomed Inst 新穎的苯并咪唑衍生物290
US20100074896A1 (en) * 2006-11-30 2010-03-25 The Johns Hopkins University Antagonists of pge2 ep3 receptors
AU2007331471C1 (en) 2006-12-15 2013-07-25 Glaxo Group Limited Benzamide derivatives as EP4 receptor agonists
GB0701970D0 (en) * 2007-02-01 2007-03-14 Wilson Stuart Treatment of protein aggregation diseases
JP5408434B2 (ja) * 2007-07-03 2014-02-05 アステラス製薬株式会社 アミド化合物
GB0721611D0 (en) 2007-11-02 2007-12-12 Glaxo Group Ltd Novel compounds
EP2565191B1 (en) * 2008-05-14 2014-10-08 Astellas Pharma Inc. 4-(Indol-7-ylcarbonylaminomethyl)cyclohexanecarboxylic acid derivatives as EP4 receptor antagonists useful for the treatment of chronic renal failure or diabetic nephropathy
EP2392323A4 (en) 2009-01-30 2012-09-26 Univ Kyoto INHIBITOR OF PROSTATE CANCER PROGRESSION AND METHOD OF INHIBITING PROGRESSION
CA2777782C (en) * 2009-10-15 2016-06-28 Children's Medical Center Corporation Sepiapterin reductase inhibitors for the treatment of pain
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
DK2970265T3 (en) * 2013-03-15 2018-10-01 Plexxikon Inc HETEROCYCLIC COMPOUNDS AND APPLICATIONS THEREOF
US20140303121A1 (en) 2013-03-15 2014-10-09 Plexxikon Inc. Heterocyclic compounds and uses thereof
EP2970177A1 (en) 2013-03-15 2016-01-20 Pfizer Inc. Indole compounds that activate ampk
JP7211358B2 (ja) * 2017-05-22 2023-01-24 小野薬品工業株式会社 Ep4アンタゴニスト
US10717735B2 (en) 2017-10-13 2020-07-21 Plexxikon Inc. Solid forms of a compound for modulating kinases
US20230390303A1 (en) 2020-11-13 2023-12-07 Ono Pharmaceutical Co., Ltd. Cancer treatment by combination of ep4 antagonist and immune checkpoint inhibitor

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4251446A (en) * 1977-03-01 1981-02-17 Sterling Drug Inc. Phthalide compounds, processes and marking systems
US4322352A (en) * 1979-04-04 1982-03-30 Sterling Drug Inc. Indolyl phthalide compounds
JPS62138469A (ja) * 1985-12-11 1987-06-22 Yoshitomi Pharmaceut Ind Ltd インド−ル誘導体
US5075313A (en) * 1990-09-13 1991-12-24 Eli Lilly And Company 3-aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof
GB9022785D0 (en) * 1990-10-19 1990-12-05 Merck Sharp & Dohme Therapeutic agents
WO1997021435A1 (en) * 1995-12-14 1997-06-19 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
JP2000516958A (ja) * 1996-08-26 2000-12-19 ジェネティックス・インスチチュート・インコーポレーテッド ホスホリパーゼ酵素の阻害剤
JPH1171336A (ja) * 1997-06-25 1999-03-16 Mitsubishi Chem Corp アミド誘導体
WO2000006550A1 (en) * 1998-07-31 2000-02-10 Nippon Soda Co., Ltd. Phenylazole compounds, process for producing the same and drugs for hyperlipemia
US6437146B1 (en) * 1998-09-25 2002-08-20 Fujisawa Pharmaceutical Co., Ltd. Oxazole compounds as prostaglandin e2 agonists or antagonists
JP2002527393A (ja) * 1998-10-15 2002-08-27 メルク エンド カムパニー インコーポレーテッド 骨吸収阻害方法
GB9902455D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
EP1312601A4 (en) * 2000-08-22 2005-09-21 Ono Pharmaceutical Co CARBOXYLENE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND MEDICAMENTS CONTAINING THEM AS AN ACTIVE SUBSTANCE
JP4212358B2 (ja) * 2000-12-28 2009-01-21 第一三共株式会社 Vla−4阻害薬

Similar Documents

Publication Publication Date Title
JP2004517098A5 (https=)
JP2004517099A5 (https=)
JP2009536660A5 (https=)
RU2116789C1 (ru) Способ ингибирования вирусных инфекций гепатита в
JP2020169171A5 (https=)
JP2006507265A5 (https=)
JP2005511699A5 (https=)
JP2001247459A5 (https=)
JP2004517847A5 (https=)
JP2005511531A5 (https=)
JP2012503621A5 (https=)
RU2008145714A (ru) Пуриновые производные в качестве активатора аденозинового рецептора
JP2011509309A5 (https=)
JP2005507878A5 (https=)
JP2004517130A5 (https=)
JP2002535401A5 (https=)
RU95113148A (ru) Производное 2-(2-амино-1,6-дигидро-6-оксопурин-9-ил)-метокси-1,3-пропандиола
JP2003532640A5 (https=)
JP2003512327A5 (https=)
EP0992509A3 (en) Novel macrolide derivatives
JP2006510606A5 (https=)
RU2003130644A (ru) Производные ркарболина и их фармацевтическое применение против дипрессии и страха
JP2003513075A5 (https=)
JP2005516898A5 (https=)
JP2004538278A5 (https=)